Likarda is a biotech developing cell therapies and enabling technologies to transform the way cell therapies are delivered and function.
Likarda's investors include Bill & Melinda Gates Foundation, Missouri Technology Corporation, Werth Ventures.
Likarda is headquartered in Cambridge, United States.
Likarda is a biotech developing cell therapies and enabling technologies to transform the way cell therapies are delivered and function.
Likarda is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Likarda — Funding & Investors." VCBacked, March 12, 2025, https://www.vcbacked.co/company/likarda. Accessed November 13, 2026.
VCBacked. (2025). Likarda — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/likarda
{{cite web |title=Likarda — Funding & Investors |url=https://www.vcbacked.co/company/likarda |website=VCBacked |access-date=November 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Likarda? Request a listing update